Immediate Impact
6 standout
Citing Papers
Breast cancer: pathogenesis and treatments
2025 Standout
Clinicopathologic Characteristics and Prognosis of ERBB2-Low Breast Cancer Among Patients in the National Cancer Database
2023 Standout
Works of Shu Yazaki being referenced
Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective study
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shu Yazaki | 40 | 9 | 15 | 11 | 8 | 43 | |
| Stephen Giilck | 21 | 13 | 13 | 10 | 5 | 34 | |
| Jade M. van Berge Henegouwen | 25 | 7 | 10 | 17 | 12 | 36 | |
| Beatriz Rojas | 18 | 7 | 10 | 7 | 6 | 29 | |
| Estefanía Monturus | 44 | 25 | 8 | 18 | 6 | 51 | |
| Carsten Hielscher | 29 | 7 | 10 | 3 | 8 | 42 | |
| Yiu-Keung Lau | 26 | 4 | 9 | 19 | 10 | 51 | |
| Diana Bello Roufai | 30 | 10 | 5 | 16 | 8 | 44 | |
| Vesna Glavicic | 33 | 6 | 21 | 20 | 11 | 48 | |
| Qilong Zhang | 41 | 11 | 14 | 29 | 8 | 50 | |
| Adrián Nervo | 51 | 6 | 32 | 12 | 10 | 61 |
All Works
Loading papers...